Single-use Bioprocessing Material Market by Product, and End User - Global Opportunity Analysis and Industry Forecast, 2017-2023

  • ID: 4580572
  • Report
  • Region: Global
  • 180 pages
  • Allied Analytics LLP
1 of 4
Single-use bioprocessing technology consists of disposable products that assist in manufacturing biopharmaceutical products. This technology has been rapidly adopted by various biopharmaceutical companies in the recent years. The key factors that drive the demand for single-use bioprocessing products include rise in adoption of single use technologies across pharmaceutical manufacturing facilities, low risk of product cross contamination, cost-effectiveness, and less floor space requirement. This has further led to the development of single-use bioprocessing products using advanced materials as shelf-life of SUB products relies upon the stability of plastic ware and its sterility.

The global single-use bioprocessing material market is segmented on the basis of product, end user, and geography. Based on the product the market is classified into plastic, silicone, and other. Further, the plastic material is sub-categorized into polyethylene, polyvinyl chloride, polyamide, and other plastic material. On the basis of end user, the single-use bioprocessing material market is divided into biopharmaceutical manufacturers, life science R&D and academic research, and contract research organization & manufacturers. The plastic segment has generated the highest revenue in the global market in 2016 and is anticipated to maintain the dominance throughout the forecast period. In addition, contract research organization & manufacturers is expected to grow at the fastest pace from 2017-2023.

Geographically, the single-use bioprocessing material market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America dominated the single-use bioprocessing material market as it favors the introduction of novel single-use bioprocessing products and the regional manufacturers keenly invest in the development of materially advanced single-use bioprocessing products. Whereas, Asia-Pacific has registered highest growth rate from 2017-2023.

KEY BENEFITS FOR STAKEHOLDERS

The study provides an in-depth analysis of the global single-use bioprocessing material market with the current trends and future estimations to elucidate the imminent investment pockets.
Comprehensive analysis of the factors that drive and restrict the market growth is provided.
Comprehensive quantitative analysis of the industry is provided from 2016 to 2023 to assist stakeholders to capitalize on the prevailing market opportunities.
Extensive analysis of the key segments of the industry helps to understand the trends in single-use bioprocessing material globally.
Key players and their strategies are provided to understand the competitive outlook of the industry.

KEY MARKET SEGMENTS

By Product

Plastic
Polyethylene
Polyvinyl chloride
Polyamide
Other Plastic Materials
Silicone
Other

By End User

Biopharmaceutical Manufacturers
Life Science R&D and Academic Research Institutes
Contract Research Organization & Manufacturers

By Region

North America
U.S.
Canada
Mexico
Europe
UK
France
Germany
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
Rest of Asia-Pacific
LAMEA
Brazil
Turkey
Argentina
South Africa
Rest of LAMEA

KEY MARKET PLAYERS

Thermo Fisher Scientific
Danaher Corporation
GE Healthcare (General Electric Company)
Sartorius Stedim Biotech S.A
Merck Millipore (Merck Group)
3M Company
Eppendorf AG
Finesse Solutions, Inc.
Applikon Biotechnology B.V.
Cesco Bioengineering Co., Ltd.

The other players in the value chain include (profiles not included in the report)

Octane Biotech Inc.
PBS Biotech, Inc.
Meissner Filtration Products, Inc.
Sentinel Process Systems Inc.
CMC Biologics (Asahi Glass Co.)
Novasep
PendoTECH
BioPure Technology Ltd.
READ MORE
Note: Product cover images may vary from those shown
2 of 4
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.3. Porters five forces analysis
3.4. Market share analysis/Top player positioning, 2016
3.5. Market dynamics
3.5.1. Drivers
3.5.1.1. Rising preference for use of high-grade polymeric materials
3.5.1.2. Increasing use of advanced materials in the development of single-use bioprocess films
3.5.2. Restraints
3.5.2.1. Concerns regarding largescale disposal of plastic derivatives
3.5.3. Opportunity
3.5.3.1. Incorporation of cost-effective materials in the construction of SUB products

CHAPTER 4: SINGLE-USE BIOPROCESSING MATERIAL MARKET, BY PRODUCT
4.1. Overview
4.1.1. Market size and forecast
4.2. Plastic
4.2.1. Key trends and opportunities
4.2.2. Market size and forecast
4.2.3. Market analysis, by country
4.3. Silicone
4.3.1. Key trends and opportunities
4.3.2. Market size and forecast
4.3.3. Market analysis, by country
4.4. Other
4.4.1. Key trends and opportunities
4.4.2. Market size and forecast
4.4.3. Market analysis, by country

CHAPTER 5: SINGLE-USE BIOPROCESSING MATERIAL MARKET, BY END USER
5.1. Overview
5.1.1. Market size and forecast
5.2. Biopharmaceutical manufacturers
5.2.1. Market size and forecast
5.2.2. Market analysis, by country
5.3. Life science R&D and academic institutes
5.3.1. Market size and forecast
5.3.2. Market analysis, by country
5.4. Contract research and manufacturing organizations
5.4.1. Market size and forecast
5.4.2. Market analysis, by country

CHAPTER 6: SINGLE-USE BIOPROCESSING MATERIAL MARKET, BY REGION
6.1. Overview
6.1.1. Market size and forecast
6.2. North America
6.2.1. Key trends and opportunities
6.2.2. North America market size and forecast, by country
6.2.2.1. U.S. market size and forecast, by product
6.2.2.2. U.S. market size and forecast, by end user
6.2.2.3. Canada market size and forecast, by product
6.2.2.4. Canada market size and forecast, by end user
6.2.2.5. Mexico market size and forecast, by product
6.2.2.6. Mexico market size and forecast, by end user
6.2.3. North America market size and forecast, by product
6.2.4. North America market size and forecast, by end user
6.3. Europe
6.3.1. Key trends and opportunities
6.3.2. Europe market size and forecast, by country
6.3.2.1. UK market size and forecast, by product
6.3.2.2. UK market size and forecast, by end user
6.3.2.3. Germany market size and forecast, by product
6.3.2.4. Germany market size and forecast, by end user
6.3.2.5. France market size and forecast, by product
6.3.2.6. France market size and forecast, by end user
6.3.2.7. Spain market size and forecast, by product
6.3.2.8. Spain market size and forecast, by end user
6.3.2.9. Italy market size and forecast, by product
6.3.2.10. Italy market size and forecast, by end user
6.3.2.11. Rest of Europe market size and forecast, by product
6.3.2.12. Rest of Europe market size and forecast, by end user
6.3.3. Europe market size and forecast, by product
6.3.4. Europe market size and forecast, by end user
6.4. Asia-Pacific
6.4.1. Key trends and opportunities
6.4.2. Asia-Pacific market size and forecast, by country
6.4.2.1. Japan market size and forecast, by product
6.4.2.2. Japan market size and forecast, by end user
6.4.2.3. China market size and forecast, by product
6.4.2.4. China market size and forecast, by end user
6.4.2.5. India market size and forecast, by product
6.4.2.6. India market size and forecast, by end user
6.4.2.7. Australia market size and forecast, by product
6.4.2.8. Australia market size and forecast, by end user
6.4.2.9. Rest of Asia-Pacific market size and forecast, by product
6.4.2.10. Rest of Asia-Pacific market size and forecast, by end user
6.4.3. Asia-Pacific market size and forecast, by product
6.4.4. Asia-Pacific market size and forecast, by end user
6.5. LAMEA
6.5.1. Key trends and opportunities
6.5.2. LAMEA market size and forecast, by country
6.5.2.1. Brazil market size and forecast, by product
6.5.2.2. Brazil market size and forecast, by end user
6.5.2.3. Turkey market size and forecast, by product
6.5.2.4. Turkey market size and forecast, by end user
6.5.2.5. South Africa market size and forecast, by product
6.5.2.6. South Africa market size and forecast, by end user
6.5.2.7. Argentina market size and forecast, by product
6.5.2.8. Argentina market size and forecast, by end user
6.5.2.9. Rest of LAMEA market size and forecast, by product
6.5.2.10. Rest of LAMEA market size and forecast, by end user
6.5.3. LAMEA market size and forecast, by product
6.5.4. LAMEA market size and forecast, by end user

CHAPTER 7: COMPANY PROFILES
7.1. 3M Company
7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Operating business segments
7.1.4. Business performance
7.1.5. Key strategic moves and developments
7.2. Applikon Biotechnology
7.2.1. Company overview
7.2.2. Company snapshot
7.2.3. Operating business segments
7.2.4. Business performance
7.2.5. Key strategic moves and developments
7.3. Cesco Bioengineering Co. Ltd.
7.3.1. Company overview
7.3.2. Company snapshot
7.3.3. Operating business segments
7.3.4. Business performance
7.3.5. Key strategic moves and developments
7.4. Danaher Corporation
7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Operating business segments
7.4.4. Business performance
7.4.5. Key strategic moves and developments
7.5. Eppendorf AG
7.5.1. Company overview
7.5.2. Company snapshot
7.5.3. Operating business segments
7.5.4. Business performance
7.5.5. Key strategic moves and developments
7.6. General Electric Company
7.6.1. Company overview
7.6.2. Company snapshot
7.6.3. Operating business segments
7.6.4. Business performance
7.6.5. Key strategic moves and developments
7.7. Merck KGaA
7.7.1. Company overview
7.7.2. Company snapshot
7.7.3. Operating business segments
7.7.4. Business performance
7.7.5. Key strategic moves and developments
7.8. PBS Biotech Inc.
7.8.1. Company overview
7.8.2. Company snapshot
7.8.3. Operating business segments
7.8.4. Business performance
7.8.5. Key strategic moves and developments
7.9. Sartorius Stedim Biotech S.A.
7.9.1. Company overview
7.9.2. Company snapshot
7.9.3. Operating business segments
7.9.4. Business performance
7.9.5. Key strategic moves and developments
7.10. Thermo Fisher Scientific inc.
7.10.1. Company overview
7.10.2. Company snapshot
7.10.3. Operating business segments
7.10.4. Business performance
7.10.5. Key strategic moves and developments
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
According to a new report titled, Single-use Bioprocessing Material Market by Product and End User: Global Opportunity Analysis and Industry Forecast, 2017-2023" the global single-use bioprocessing material market was valued at $2,800.0 million in 2016, and is projected to reach $9,342.1 million by 2023, growing at a CAGR of 18.7% from 2017 to 2023. The plastic segment accounted for five-eighths share of the global market in 2016.

Single-use bioprocessing technology has gained significant traction in the recent years, owing to the rapid adoption of disposable bioprocessing equipment by pharmaceutical manufacturers. This has fueled the manufacturers to integrate different materials in the construction of single-use bioprocessing products. These products have also proved beneficial for the small scale pharmaceutical manufacturers. Hence, most biopharmaceutical companies utilize single-use bioprocessing technology for manufacturing vaccines, monoclonal antibodies, and other pharmaceutical components on commercial scale. This has spurred the demand for high-grade plastic and silicone materials in the development of SUB products.

The polyethylene segment is the major contributor to the revenue generated by the plastic segment is 2016 and is anticipated to maintain this dominance throughout the forecast period. Variants of polyethylene, such as high-density polyethylene (HDPE), low-density polyethylene (LDPE), and medium-density polyethylene (MDPE) are used to manufacture single-use bioprocessing products. In addition, polyethylene is extensively used in the construction of media bags along with the films used in the bioprocess containers.

Moreover, biopharmaceutical manufacturers segment has dominated the global market in 2016 and is anticipated to maintain this trend throughout the forecast period. The major driving force of the increasing utilization of single-use bioprocessing systems is the collaboration between leading manufacturers and small-scale suppliers of filtration, container or closure systems, mixing systems, fermentation systems, and cell culture systems (bioreactors).

Key findings of the Single-use Bioprocessing Material Market:

The silicone material segment accounted for second largest share in the global market in 2016 and is expected to maintain this trend throughout the forecast period.
Other plastic material segment is anticipated to grow at the fastest pace from 2017-2023.
Contract research organization & manufacturers registered highest growth in the global single-use bioprocessing material market during the forecast period.
North America dominated the single-use bioprocessing material market in 2016 and is anticipated to maintain this trend throughout the forecast period.
UK is anticipated to grow at the fastest pace in the European single-use bioprocessing market during the forecast period.

Asia-Pacific witnessed highest growth rate for single-use bioprocessing market and is expected to continue this trend throughout the forecast period. This is attributed to the rise in expenditure on healthcare along with the improvement in medical and healthcare infrastructure. In addition, the key market players focus on the opportunities offered by the growing demand for single-use bioprocess systems. Such systems are highly cost-effective, which has gained popularity among end users in this region. Moreover, significant growth of pharmaceutical and the biotechnology industries across the countries of Asia-Pacific region have supplemented the market growth.

The major companies profiled in the report include Thermo Fisher Scientific, Danaher Corporation, GE Healthcare (General Electric Company), Sartorius Stedim Biotech S.A, Merck Millipore (Merck Group), 3M Company, Eppendorf AG, Finesse Solutions, Inc., Applikon Biotechnology B.V., and Cesco Bioengineering Co., Ltd. The other companies profiled in this report include Octane Biotech Inc., PBS Biotech, Inc., Meissner Filtration Products, Inc., Sentinel Process Systems Inc., CMC Biologics (Asahi Glass Co.), Novasep, PendoTECH, and BioPure Technology Ltd.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll